Channelopathies converge on TRPV4
- PMID: 20104247
- DOI: 10.1038/ng0210-98
Channelopathies converge on TRPV4
Abstract
Scapuloperoneal spinal muscular atrophy and Charcot-Marie-Tooth disease type 2C are inherited neurodegenerative diseases characterized by sensory defects and muscle weakness. Three new studies demonstrate that they are allelic disorders caused by mutations in the vanilloid transient receptor potential cation-channel gene TRPV4.
Comment on
-
Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C.Nat Genet. 2010 Feb;42(2):170-4. doi: 10.1038/ng.512. Epub 2009 Dec 27. Nat Genet. 2010. PMID: 20037586 Free PMC article.
-
Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4.Nat Genet. 2010 Feb;42(2):165-9. doi: 10.1038/ng.509. Epub 2009 Dec 27. Nat Genet. 2010. PMID: 20037587 Free PMC article.
-
Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C.Nat Genet. 2010 Feb;42(2):160-4. doi: 10.1038/ng.508. Epub 2009 Dec 27. Nat Genet. 2010. PMID: 20037588 Free PMC article.
Similar articles
-
Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4.Nat Genet. 2010 Feb;42(2):165-9. doi: 10.1038/ng.509. Epub 2009 Dec 27. Nat Genet. 2010. PMID: 20037587 Free PMC article.
-
Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C.Nat Genet. 2010 Feb;42(2):160-4. doi: 10.1038/ng.508. Epub 2009 Dec 27. Nat Genet. 2010. PMID: 20037588 Free PMC article.
-
A TRPV4 mutation caused Charcot-Marie-Tooth disease type 2C with scapuloperoneal muscular atrophy overlap syndrome and scapuloperoneal spinal muscular atrophy in one family: a case report and literature review.BMC Neurol. 2023 Jun 30;23(1):250. doi: 10.1186/s12883-023-03260-0. BMC Neurol. 2023. PMID: 37391745 Free PMC article. Review.
-
Phenotypic variability of TRPV4 related neuropathies.Neuromuscul Disord. 2015 Jun;25(6):516-21. doi: 10.1016/j.nmd.2015.03.007. Epub 2015 Mar 18. Neuromuscul Disord. 2015. PMID: 25900305 Free PMC article.
-
TRPV4-mediated channelopathies.Channels (Austin). 2010 Jul-Aug;4(4):319-28. doi: 10.4161/chan.4.4.12905. Epub 2010 Jul 6. Channels (Austin). 2010. PMID: 20676052 Review.
Cited by
-
Targeting TRP channels: recent advances in structure, ligand binding, and molecular mechanisms.Front Mol Neurosci. 2024 Jan 11;16:1334370. doi: 10.3389/fnmol.2023.1334370. eCollection 2023. Front Mol Neurosci. 2024. PMID: 38273937 Free PMC article. Review.
-
Structural Pharmacology of TRPV4 Antagonists.Adv Sci (Weinh). 2024 Jul;11(25):e2401583. doi: 10.1002/advs.202401583. Epub 2024 Apr 24. Adv Sci (Weinh). 2024. PMID: 38659239 Free PMC article.
-
Pathophysiological Roles of the TRPV4 Channel in the Heart.Cells. 2023 Jun 17;12(12):1654. doi: 10.3390/cells12121654. Cells. 2023. PMID: 37371124 Free PMC article. Review.
-
Identification and Properties of TRPV4 Mutant Channels Present in Polycystic Kidney Disease Patients.Function (Oxf). 2024 Sep 10;5(5):zqae031. doi: 10.1093/function/zqae031. Function (Oxf). 2024. PMID: 38984987 Free PMC article.
-
Transient receptor potential channelopathies.Pflugers Arch. 2010 Jul;460(2):437-50. doi: 10.1007/s00424-010-0788-2. Epub 2010 Feb 4. Pflugers Arch. 2010. PMID: 20127491 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources